Cell Source Depreciation & Amortization Growth & History (CLCS)

Cell Source's depreciation and amortization was $0 for fiscal 2018.

View full Cell Source company overview

Cell Source annual depreciation and amortization history

Cell Source annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20182018-12-31$0−$407
20172017-12-31$407−$453−52.67%
20162016-12-31$860$00.00%
20152015-12-31$860$405+89.01%
20142014-12-31$455$455
20132013-12-31$0

Cell Source depreciation and amortization trends

Over the last five fiscal years, Cell Source's depreciation and amortization increased from $0 to $0, a change of $0. The latest reported quarter, Q3 2017, shows $0.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post